NRX Pharmaceuticals Warrant (NRXPW)

• Market cap: $1.97K
• 1 day: -21.43%
• 5 days: -30.38%
• 1 month: -77.91%
• 3 months: -90.69%
• 6 months: -95.37%
• Year to date: -91.91%
• 1 year: -90.92%
• 5 years: -99.91%
• 10 years: -98.44%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Employees: 29